Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manabu Shirakawa has a total of 170 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and validation of a machine learning model for predicting intracranial atherosclerotic disease in large vessel occlusion prior to endovascular therapy

    by Junichi Kouno, Kazutaka Uchida, Takufumi Yanagisawa, Fumihiro Sakakibara, Manabu Shirakawa, Nobuyuki Sakai, Haruhiko Kishima, Shinichi Yoshimura


  • Open Access

    Contrast‐Enhanced 3T Vessel Wall Imaging for Symptomatic Intracranial Atherosclerotic Stenosis: Value of Pituitary Stalk Reference

    by Kensaku Senda, Manabu Shirakawa, Kazutaka Uchida, Fumihiro Sakakibara, Kiyofumi Yamada, Shinichi Yoshimura

    Background: Three‐dimensional vessel wall imaging (VWI) using 3T MRI enables detailed assessment of intracranial atherosclerotic stenosis (ICAS), but the optimal reference tissue and its clinical utility remain unclear. This study aimed to identify the most suitable reference tissue for contrast‐enhanced (CE) VWI and to clarify imaging differences between symptomatic and asymptomatic ICAS. Methods: We retrospectively analyzed 45 patients with 56 ICAS lesions undergoing CE‐VWI between April 2016 and August 2024. Exclusion criteria included complete occlusion, non‐atherosclerotic vascular disease, embolism, ≥ 50% ipsilateral cervical internal carotid artery (ICA) stenosis, and poor image quality. Lesions imaged within 3 months of transient ischemic attack (TIA) or infarction were defined as symptomatic; those imaged > 3 months post‐onset or without ischemic history were classified as asymptomatic. VWI sequences included 3D time ‐of‐flight MR angiography (TOF‐MRA), non‐contrast‐enhanced (non‐CE), and CE T1‐weighted imaging (T1WI) using improved motion‐sensitized driven equilibrium‐3D turbo spin echo (TSE). Signal intensity ratios of the vessel wall to surrounding tissues (brain parenchyma, gray matter, optic chiasm, muscle, and pituitary stalk) were calculated, along with wall thickness at the stenotic site. Results: Among 56 lesions, 24 were symptomatic and 18 asymptomatic. Baseline characteristics were similar between groups. The vessel wall intensity ratio was significantly higher in symptomatic lesions across all reference tissues in both non‐CE and CE‐VWI. The ratio using the pituitary stalk in CE‐VWI showed the best discriminatory performance. Conclusion: CE‐VWI using the pituitary stalk as a reference tissue provides high discriminatory value in differentiating symptomatic from asymptomatic ICAS, supporting imaging‐based diagnosis of relevant ICAS.


  • Open Access

    Preoperative Neurological Changes on Outcomes in Large-Vessel Occlusion Due to Intracranial Atherosclerotic Disease

    by Takeshi Yoshimoto, Kanta Tanaka, Junpei Koge, Kazutaka Uchida, Hirotoshi Imamura, Kazunori Toyoda, Hiroshi Yamagami, Nobuyuki Sakai, Manabu Shirakawa, Mikiya Beppu, et al.

    BACKGROUND AND OBJECTIVES: We aimed to clarify the association between neurological deterioration pre-endovascular therapy (EVT) and outcome in patients with large-vessel occlusion due to intracranial atherosclerotic disease (ICAD-LVO) undergoing EVT. METHODS: Consecutive patients with acute ischemic stroke due to ICAD-LVO within 24 h of onset who underwent EVT were enrolled in the Japanese multicenter registry from 2017 to 2019. Patients were grouped according to neurological severity transition as follows: mild symptoms (baseline National Institutes of Health Stroke Scale [NIHSS] score <6 and NIHSS score pre-EVT <6), symptom deterioration (baseline NIHSS score <6 and NIHSS score pre-EVT ≥6), and severe symptoms (baseline NIHSS score ≥6 and NIHSS score pre-EVT ≥6). Outcomes included favorable outcomes (modified Rankin Scale [mRS] score of 0-2 at 90 days), ordinal mRS shift, and symptomatic intracranial hemorrhage. Multivariable logistic regression assessed the association of outcomes with the transition of neurological severity by calculating odds ratios and 95% CIs, with mild symptoms as reference. RESULTS: In total, 480 patients with acute ICAD-LVO who underwent EVT (150 women [31.2%]; median age, 72 years IQR, 66-80) and had median baseline NIHSS score 12 (IQR, 6-20) were analyzed. Patients with symptom deterioration (n = 34) and severe symptoms (n = 375) had lower favorable outcomes (deterioration 38.2% vs mild 62.9%; adjusted odds ratio 0.30, 95% CI 0.09-0.97, severe 35.3%; 0.47, 0.33-0.65) and a significant mRS shift (deterioration vs mild; 3.63, 1.46-9.03, severe; 2.27, 1.74-2.96) than those with mild symptoms (n = 71). Symptomatic intracranial hemorrhage rates did not differ (mild 0%; deterioration 0%; severe 1.9%). CONCLUSION: Patients with ICAD-LVO who experienced worsening symptoms were less likely to achieve favorable outcomes after EVT than those with mild symptoms. Early identification of neurological deterioration and EVT intervention may improve outcomes in these patients.


  • Outcomes of carotid artery stenting in patients aged 80 years or older with asymptomatic carotid artery stenosis

    by Fuminori Shimizu, Kazutaka Uchida, Manabu Shirakawa, Fumihiro Sakakibara, Satoru Fujiwara, Koji Iihara, Hirotoshi Imamura, Akira Ishii, Yuji Matsumaru, Chiaki Sakai, et al.

    Background and objectives: The outcomes of carotid artery stenting (CAS) for asymptomatic patients aged ≥80 years remain unclear. This study aimed to investigate the procedural and functional outcomes of CAS in these patients. Methods: This was a post-hoc analysis of a nationwide retrospective registry of patients with asymptomatic carotid artery stenosis who underwent CAS. The primary outcome was a composite of ischemic stroke and all-cause death. The secondary outcomes were ischemic stroke, all-cause death, acute occlusion, and acute myocardial infarction. Functional outcomes were assessed using the modified Rankin Scale (mRS). The outcomes were assessed 30 days post-procedure and compared between patients aged ≥80 years and <80 years. Results: Overall, 4549 patients were evaluated. Pre-procedural mRS and the prevalence of ≥80% stenosis were higher in the ≥80-year-old group. Calcified lesions and high risk for carotid endarterectomy were more common in the ≥80-year-old group. No significant between-group differences were found in primary and secondary outcomes. However, the functional outcomes were significantly worse in the ≥80-year-old group, with a higher proportion of patients with worse mRS score (ie, decreasing at least one point) at follow-up (11.2% vs 5.0%; adjusted OR 2.24 (95% CI 1.66 to 3.02)). Conclusion: CAS for asymptomatic carotid artery stenosis is associated with poorer 30-day functional outcomes in patients aged ≥80 years than in those aged <80 years, but the composite of ischemic stroke and all-cause death is not significantly different between the two age groups.


  • Open Access

    Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry

    by Hirotaka Hayashi, Satoshi Namitome, Seigo Shindo, Shinichi Yoshimura, Manabu Shirakawa, Mikiya Beppu, Nobuyuki Sakai, Hiroshi Yamagami, Kazutaka Uchida, Kazunori Toyoda, et al.

    Background: Whether intravenous thrombolysis (IVT) should be administered prior to endovascular therapy (EVT) in patients with atherothrombotic stroke-related large vessel occlusion (AT-LVO) remains unclear. This study aimed to assess the efficacy and safety of IVT administered before EVT in this patient population. Methods: We analysed the data from a multicentre registry of patients who underwent EVT for AT-LVO. Patients were categorised based on presumed mechanism of occlusion: in situ occlusion (intracranial group) or embolism from cervical artery occlusion/stenosis (tandem group). We compared the efficacy and safety of IVT before EVT in patients who received IVT (IVT stratum) and those who did not (non-IVT stratum). The primary outcome was a modified Rankin Scale score of 0–2 at 90 days. Results: Among the 336 patients in the intracranial group, 99 patients underwent IVT. The rate of favourable functional outcomes did not differ between IVT and non-IVT strata (51.1% vs 47.6%; adjusted ORs (aORs) (95% CI), 1.18 (0.66 to 2.09)); whereas any intracranial haemorrhage (ICH) (10.1% vs 3.8%; aOR, 2.98 (1.01 to 9.26)) and mortality at 90 days (6.4% vs 1.3%; aOR, 4.66 (1.02 to 26.73)) were significantly higher in the IVT stratum. Among the 233 patients in the tandem group, 88 patients underwent IVT, with no significant differences in efficacy or safety outcomes between the strata. Conclusion: In patients with AT-LVO, IVT before EVT did not improve outcomes and was associated with increased risk of ICH and mortality in those with in situ intracranial occlusion. IVT before EVT may not be recommended in patients with atherosclerotic intracranial occlusions.


  • Open Access

    Clinical features of pasteurellosis without an animal bite or scratch in comparison with bite/scratch pasteurellosis

    by Tsubasa Asaeda, Takashi Ueda, Yasuhiro Nozaki, Yasushi Murakami, Mika Morosawa, Hiroko Inaba, Hitoshi Ogashiwa, Miki Doi, Kazuhiko Nakajima, Manabu Shirakawa, et al.


  • Perioperative Antiplatelet Management in the Flow-Diverter Treatment for Unruptured Cerebral Aneurysms: A Single-Center, Retrospective Analysis

    by Masataka Miyama, Hidetoshi Matsukawa, Fumihiro Sakakibara, Kazutaka Uchida, Manabu Shirakawa, Shinichi Yoshimura


  • 3D phase-sensitive inversion recovery sequence for intracranial vertebrobasilar artery dissection

    by Takuya Enoki, Katsuhiro Kida, Wataru Jomoto, Yusuke Kawanaka, Manabu Shirakawa, Masataka Miyama, Noriko Kotoura, Sachiko Goto


  • Open Access

    Computed Tomography Perfusion Parameters Predictive of Symptomatic Intracranial Hemorrhage After Mechanical Thrombectomy in Patients With Cerebral Large Vessel Occlusion

    by Soichiro Abe, Manabu Inoue, Manabu Shirakawa, Kazutaka Uchida, Kiyofumi Yamada, Yoji Kuramoto, Satoshi Namitome, Seigo Shindo, Fumihiro Sakakibara, Junichi Kouno, et al.

    Background: Hemorrhagic transformation after recanalization is a severe complication in patients with a large ischemic core due to cerebral large vessel occlusion. Risk assessment using perfusion imaging to predict hemorrhagic infarction has not been established. Thus, we aimed to investigate the association between perfusion imaging findings and hemorrhagic transformation in patients with acute cerebral large vessel occlusion who had undergone preoperative perfusion imaging evaluation and mechanical thrombectomy. Methods: We enrolled consecutive patients who received mechanical thrombectomy after undergoing perfusion imaging for anterior large vessel occlusion from May 2019 to March 2022. The patients in whom recanalization were not achieved and who experienced procedure‐related bleeding were excluded. We investigated the predictors of symptomatic intracranial hemorrhage (sICH) by exploring preoperative perfusion imaging parameters (relative cerebral blood flow, relative cerebral blood volume, time of maximum concentration, and hypoperfusion index ratio). Results: Among the 167 patients (median age 79 years, 47% female) enrolled, 63 (38%) and 14 (8%) patients had any intracranial hemorrhage and sICH (sICH group), respectively. The sICH group had a shorter puncture‐recanalization time than the non‐sICH group (median [interquartile range (IQR)]; 43 [34–55] versus 61 [37–88]; P =0.046), whereas the modified Rankin scale at 90 days showed a worse prognosis (median [IQR]; 5 [5–6] versus 3 [1–4]; P <0.01). All perfusion imaging parameters were significantly predicting the sICH group in multiple logistic regression analysis. The value of relative cerebral blood volume was the parameter most strongly associated with sICH in receiver operating characteristic curve analysis (area under the curve=0.90, 95% CI [0.83–0.98]; cutoff 43 mL; sensitivity, 86 %; specificity, 87%). Conclusion: Among perfusion computed tomography parameters, relative cerebral blood volume is highly associated with sICH after mechanical thrombectomy for cerebral large vessel occlusion. In patients with low relative cerebral blood volume regions, the indication of mechanical thrombectomy should be carefully considered for postoperative intracranial hemorrhage.


  • Number of Passes of Endovascular Therapy for Stroke With a Large Ischemic Core: Secondary Analysis of RESCUE-Japan LIMIT

    by Satoshi Namitome, Kazutaka Uchida, Seigo Shindo, Shinichi Yoshimura, Nobuyuki Sakai, Hiroshi Yamagami, Kazunori Toyoda, Yuji Matsumaru, Yasushi Matsumoto, Kazumi Kimura, et al.

    BACKGROUND: The increased risk of intracranial hemorrhage with multiple passes in endovascular therapy (EVT) for large vessel occlusion with a large ischemic core is a concern. We explored the effect of the number of EVT passes on patients in a randomized clinical trial. METHODS: This post hoc study was the secondary analysis of RESCUE-Japan LIMIT, which was a randomized clinical trial comparing EVT and medical treatment alone for large vessel occlusion with large ischemic core. We grouped patients according to the number of passes with successful reperfusion (modified Thrombolysis in Cerebral Infarction score, ≥2b) in 1, 2, and 3 to 7 passes and failed reperfusion (modified Thrombolysis in Cerebral Infarction score, 0–2a) after any pass in the EVT group, and these groups were compared with medical treatment group. The primary outcome was modified Rankin Scale score of 0 to 3 at 90 days. Secondary outcomes were improvement in National Institutes of Health Stroke Scale score of ≥8 at 48 hours, mortality at 90 days, symptomatic intracranial hemorrhage, and any intracranial hemorrhage within 48 hours. RESULTS: The number of patients who received EVT with successful reperfusion after 1, 2, and 3 to 7 passes and failed reperfusion were 44, 23, 19, and 14, respectively, and 102 received medical treatment alone. The adjusted odds ratios (95% CIs) for the primary outcome relative to medical treatment were 5.52 (2.23–14.28) after 1 pass, 6.45 (2.22–19.30) after 2 passes, 1.03 (0.15–4.48) after 3 to 7 passes, and 1.17 (0.16–5.37) if reperfusion failed. The adjusted odds ratios (95% CIs) for any intracranial hemorrhage within 48 hours relative to medical treatment were 1.88 (0.90–3.93) after 1 pass, 5.14 (1.97–14.72) after 2 passes, 3.00 (1.09–8.58) after 3 to 7 passes, and 6.16 (1.87–24.27) if reperfusion failed. CONCLUSIONS: The successful reperfusion within 2 passes was associated with better clinical outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03702413.